Cholangiocarcinoma · Bile Duct Cancer · Yelahanka · Bangalore

Bile Duct Cancer Surgery Bangalore
Cholangiocarcinoma Specialist — Dr. Srinivas Bojanapu

Dr. Srinivas Bojanapu is an HPB surgeon in Bangalore specialising in the surgical treatment of bile duct cancer (cholangiocarcinoma), including Klatskin tumours, distal bile duct cancers, and intrahepatic cholangiocarcinoma. He provides specialist HPB surgical opinions for patients who have been told their tumour is inoperable.

Book Consultation Second Opinion: +91 87478 74888
⚠ Seek urgent evaluation for: Painless jaundice Dark urine + pale stools Unexplained weight loss Upper abdominal mass

What is Cholangiocarcinoma (Bile Duct Cancer)?

Cholangiocarcinoma is cancer that arises from the epithelial cells lining the bile ducts — the network of tubes that carry bile from the liver and gallbladder into the small intestine. The bile duct system spans from inside the liver (intrahepatic) through the liver's exit point (the hilum) down to where the bile duct enters the duodenum next to the pancreatic duct.

Bile duct cancer is relatively rare — accounting for approximately 3% of all gastrointestinal cancers globally — but its incidence is rising. In India, it is more common than in Western populations, partly related to biliary parasites, choledochal cysts, and primary sclerosing cholangitis as risk factors.

The critical characteristic of cholangiocarcinoma is that surgery is the only curative treatment. Chemotherapy and radiation can prolong survival in unresectable disease but do not cure. This makes early diagnosis and rapid referral to an HPB specialist who can determine resectability — like Dr. Srinivas Bojanapu in Yelahanka, Bangalore — essential to giving patients the best chance of cure.

Three Types of Bile Duct Cancer

Type 1 — 20%

Intrahepatic Cholangiocarcinoma

Arises from bile duct cells within the liver substance. Often presents as a liver mass on imaging and can be confused with hepatocellular carcinoma (HCC). Typically requires liver resection (hepatectomy).

Surgery: Liver resection (similar to HCC surgery)
Key marker: CA 19-9 elevated; AFP usually normal
Type 2 — 55% (most common)

Perihilar Cholangiocarcinoma (Klatskin Tumour)

Located at the liver hilum where the left and right bile ducts meet. The most common and most surgically complex type. Requires bile duct resection combined with partial liver resection in most cases. Classified by Bismuth-Corlette staging (I–IV) to plan surgery.

Surgery: Bile duct resection + hemi-hepatectomy + HJ
Resectability rate: ~30–40%
Type 3 — 25%

Distal Cholangiocarcinoma

Arises in the lower common bile duct near the pancreas and duodenum. The most favourable subtype for surgical cure. Treated with the Whipple procedure (pancreaticoduodenectomy), the same operation used for pancreatic head cancers.

Surgery: Whipple procedure (PPPD)
5-year survival (R0): 25–45%

Symptoms of Bile Duct Cancer

The most frequent first symptom is painless obstructive jaundice — jaundice that appears without severe pain, caused by tumour blockage of the bile duct. This causes a distinctive pattern: yellow skin and eyes, dark tea-coloured urine, pale clay-coloured stools, and intense skin itching as bile salts accumulate in the bloodstream.

Because these symptoms often appear only when the tumour has grown large enough to block bile flow, many patients present with locally advanced or even metastatic disease. Any new-onset painless jaundice in an adult must be investigated urgently — within days, not weeks.

A rising CA 19-9 in a patient with known primary sclerosing cholangitis (PSC) or biliary disease should also prompt urgent imaging and HPB specialist review.

Jaundice
Yellow skin and eyes (scleral icterus) — most common first sign
Dark urine
Tea or cola-coloured urine from bile pigments in blood
Pale stools
Clay-coloured or white stools — bile not reaching intestine
Pruritus
Intense skin itching from bile salt accumulation
Weight loss
Unexplained > 5% weight loss over weeks-months
Abdominal pain
Dull right upper quadrant discomfort — late sign
Fever / rigors
Suggests secondary cholangitis — requires urgent drainage

Who is at Risk of Bile Duct Cancer?

Most cholangiocarcinoma occurs without an identifiable risk factor. However, several conditions significantly increase risk:

Primary Sclerosing Cholangitis (PSC)
Strongest known risk factor. Lifetime risk of cholangiocarcinoma in PSC patients is 10–20%.
Choledochal Cyst
Congenital bile duct dilation. Excision is recommended precisely to prevent malignant transformation.
Hepatitis B & C
Particularly associated with intrahepatic cholangiocarcinoma alongside HCC risk.
Liver Cirrhosis
Any cause of cirrhosis increases intrahepatic cholangiocarcinoma risk.
Biliary Stones (hepatolithiasis)
Intrahepatic stones from recurrent pyogenic cholangitis — common in parts of Asia.
Caroli Disease
Rare congenital disorder of intrahepatic bile duct dilation. High lifetime cancer risk.

Diagnosis & Staging

Accurate staging of cholangiocarcinoma determines whether surgery is possible and which operation is needed. Dr. Srinivas reviews all imaging personally before planning surgery.

Blood tests
LFTs (bilirubin, ALP), CA 19-9, CEA, AFP (to exclude HCC), full blood count, coagulation
MRCP
Magnetic Resonance Cholangiopancreatography — maps the entire bile duct anatomy. Essential for planning Klatskin tumour resection.
CT Chest-Abdomen-Pelvis
3-phase liver CT for vascular involvement, liver volume, lymph node staging, and distant metastasis detection.
PET-CT
Selected cases to detect occult distant metastases before major resection.
ERCP / PTBD
Endoscopic or percutaneous biliary drainage to relieve jaundice before surgery, if bilirubin is very high.
Liver volumetry
Future liver remnant (FLR) calculation before major resection. Portal vein embolisation (PVE) if FLR is insufficient.

Surgical Treatment of Bile Duct Cancer

Only surgery achieves cure. The operation is tailored to the location and extent of the tumour.

Klatskin Tumour Resection

En-bloc removal of the bile duct confluence, regional lymph nodes, and partial liver (right or left hepatectomy depending on tumour extent). The biliary tract is reconstructed with a hepatico-jejunostomy. Caudate lobe (segment 1) is typically included as it drains directly to the hilum.

Duration: 5–8 hours  |  Stay: 10–14 days

Whipple Procedure (Distal CCA)

The standard operation for distal bile duct cancer. Removes the lower bile duct along with the pancreatic head, duodenum, and regional lymph nodes. The same operation performed for pancreatic head cancers. Reconstruction involves three bowel anastomoses.

Duration: 4–6 hours  |  Stay: 8–12 days

Liver Resection (Intrahepatic CCA)

Intrahepatic cholangiocarcinoma is treated like other liver tumours — by resecting the involved liver segment or lobe with adequate margins. Laparoscopic liver resection is possible for tumours in accessible segments with faster recovery.

Duration: 3–6 hours  |  Stay: 5–10 days

Palliative Biliary Bypass

For patients with unresectable disease causing obstructive jaundice, biliary drainage (endoscopic stenting, PTBD, or surgical bypass) relieves symptoms and enables chemotherapy. Metal stents provide longer patency than plastic stents for malignant biliary obstruction.

Goal: Symptom relief + enable systemic therapy
Second opinion note: Patients told their tumour is "inoperable" should seek an HPB specialist opinion. A significant proportion of Klatskin tumours deemed unresectable at non-specialist centres are resectable by an experienced HPB surgeon using extended resections.

Why Choose Dr. Srinivas for Bile Duct Cancer Surgery in Bangalore

🎓

Fellowship HPB Training

DrNB Surgical Gastroenterology (Sir Ganga Ram Hospital, Delhi) + PDF Liver Transplant & HPB Surgery (RGUHS). Specific training in complex biliary reconstruction including Klatskin tumour resection.

🔬

Specialist MDT Review

Every cholangiocarcinoma case reviewed in a multidisciplinary team with oncologists, radiologists, and hepatologists before surgery. No solo decisions on complex cases.

🏥

Complete HPB Programme

Access to full HPB support: interventional radiology (PTBD, portal vein embolisation), ERCP, oncology, and ICU at Kauvery Hospital, Electronic City.

♻️

Second Opinion Available

Told your Klatskin tumour is inoperable? Dr. Srinivas reviews these cases specifically. Extended resections including en-bloc liver resection may achieve R0 where lesser operations cannot.

📍

Accessible Location

Dhaara Liver Clinic in Yelahanka for outpatient review — no need to travel to distant city-centre hospitals for North Bangalore and Airport Road corridor patients.

💊

Post-operative Oncology Coordination

Adjuvant chemotherapy referral post-resection (BILCAP protocol, capecitabine). Molecular testing (FGFR2, IDH1) organised for patients with unresectable disease.

Frequently Asked Questions — Bile Duct Cancer

What is cholangiocarcinoma? +
Cholangiocarcinoma is cancer arising from the cells lining the bile ducts. It can develop anywhere along the bile duct system: inside the liver (intrahepatic), at the liver hilum (perihilar or Klatskin tumour), or in the lower common bile duct (distal). It is an aggressive cancer but potentially curable if caught before spread beyond the bile ducts — making early specialist referral critical.
What is a Klatskin tumour? +
A Klatskin tumour is perihilar cholangiocarcinoma — bile duct cancer at the hilum of the liver where the left and right main bile ducts converge. It accounts for 50–60% of all bile duct cancers and is the most technically complex to resect. It typically requires combined bile duct resection and partial liver resection, classified by Bismuth-Corlette staging.
What are the symptoms of bile duct cancer? +
The most common symptom is painless obstructive jaundice — yellowing of skin and eyes, dark (tea-coloured) urine, pale clay-coloured stools, and intense itching. Unexplained weight loss, upper abdominal discomfort, and fever (if cholangitis develops) are other symptoms. Any new painless jaundice must be investigated urgently — do not wait.
Is bile duct cancer curable? +
Surgery is the only curative treatment. Complete resection with clear margins (R0) achieves 5-year survival of 20–45% depending on tumour location. Unfortunately, only 30–40% of patients are resectable at diagnosis. For unresectable disease, chemotherapy (gemcitabine + cisplatin) or targeted therapies (FGFR2/IDH1 inhibitors) can prolong survival. Some patients told "inoperable" at general hospitals can have successful resection by an experienced HPB specialist.
What surgery is done for bile duct cancer? +
Surgery depends on tumour location. Klatskin (perihilar) tumours: bile duct resection + partial liver resection + hepatico-jejunostomy reconstruction. Distal bile duct cancers: Whipple procedure (pancreaticoduodenectomy). Intrahepatic cholangiocarcinoma: liver resection. All require an HPB surgeon with specific training in biliary reconstruction.
How is bile duct cancer diagnosed? +
Diagnosis uses blood tests (LFTs, CA 19-9, CEA), MRCP (maps bile duct anatomy — essential), CT staging, and sometimes PET-CT. Tissue biopsy through a jaundiced biliary system risks cholangitis — imaging diagnosis combined with CA 19-9 is often sufficient for surgical planning. Biliary drainage (stenting/PTBD) may be placed to improve jaundice before surgery.
What is survival after bile duct cancer surgery? +
5-year survival after complete (R0) resection: perihilar 20–35%, distal 25–45%, intrahepatic 25–40%. Lymph node clearance and margin status are the strongest predictors. Adjuvant chemotherapy (capecitabine, BILCAP protocol) is recommended post-resection. Survival rates have improved with better surgical techniques and molecularly targeted therapies.

Related Services

HPB Surgery → Pancreatic Cancer → Liver Cancer (HCC) → Gallbladder Cancer → GI Oncology → Liver Transplant →

Suspected Bile Duct Cancer? Get a Specialist Opinion.

Dr. Srinivas reviews patients with cholangiocarcinoma and bile duct tumours, including those told their tumour is inoperable.

Book Appointment
Call Now WhatsApp